MATTHEW ZOETEMAN: Open Payments
NPI 1356844831 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,158 in 281 payments from 20 companies in 2025. Trend: 2023 $4,411 · 2024 $6,997 · 2025 $5,158
Food & beverage: $5,062Education: $96
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $954 |
| Janssen Biotech, Inc. | 45 | $702 |
| GENZYME CORPORATION | 20 | $578 |
| UCB, Inc. | 23 | $495 |
| PFIZER INC. | 29 | $376 |
| Incyte Corporation | 19 | $373 |
| Galderma Laboratories, L.P. | 21 | $286 |
| Novartis Pharmaceuticals Corporation | 18 | $263 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $191 |
| Amgen Inc. | 11 | $186 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, Bimzelx, OPZELURA, NEMLUVIO, EUCRISA, COSENTYX.
Industry payments across MI — which companies pay providers there.
